Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Bifulco

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Cells|April 3, 2020
Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian CancerDaniela Criscuolo, Rosario Avolio, Giovanni Calice, et al.
Oncology Reports|December 4, 2009
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatinPatrizia Gazzerro, Anna M Malfitano, Maria Chiara Proto, et al.
European Journal of Medicinal Chemistry|May 25, 2018
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid systemAndrea Chicca, Chiara Arena, Simone Bertini, et al.
Diabetologia|January 12, 2024
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive childrenSara Bruzzaniti, Erica Piemonte, Dario Bruzzese, et al.
International Journal of Molecular Sciences|October 13, 2021
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity InhibitionCristina Pagano, Giovanna Navarra, Olga Pastorino, et al.
Circulation|February 28, 2002
Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signalingGiovanni Cuda, Roberto Paternò, Roberto Ceravolo, et al.
Oncotarget|May 27, 2015
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cellsElena Ciaglia, Giovanni Torelli, Simona Pisanti, et al.
Cancers|December 23, 2022
N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma CellsCristina Pagano, Laura Coppola, Giovanna Navarra, et al.
European Journal of Pharmacology|April 9, 2002
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptorsJason W Brooks, Gareth Pryce, Tiziana Bisogno, et al.
European Journal of Medicinal Chemistry|April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffoldClementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Cells|April 3, 2020
Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian CancerDaniela Criscuolo, Rosario Avolio, Giovanni Calice, et al.
Oncology Reports|December 4, 2009
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatinPatrizia Gazzerro, Anna M Malfitano, Maria Chiara Proto, et al.
European Journal of Medicinal Chemistry|May 25, 2018
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid systemAndrea Chicca, Chiara Arena, Simone Bertini, et al.
Diabetologia|January 12, 2024
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive childrenSara Bruzzaniti, Erica Piemonte, Dario Bruzzese, et al.
International Journal of Molecular Sciences|October 13, 2021
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity InhibitionCristina Pagano, Giovanna Navarra, Olga Pastorino, et al.
Circulation|February 28, 2002
Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signalingGiovanni Cuda, Roberto Paternò, Roberto Ceravolo, et al.
Oncotarget|May 27, 2015
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cellsElena Ciaglia, Giovanni Torelli, Simona Pisanti, et al.
Cancers|December 23, 2022
N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma CellsCristina Pagano, Laura Coppola, Giovanna Navarra, et al.
European Journal of Pharmacology|April 9, 2002
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptorsJason W Brooks, Gareth Pryce, Tiziana Bisogno, et al.
European Journal of Medicinal Chemistry|April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffoldClementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
Pageof 21